SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010251
Filing Date
2017-05-10
Accepted
2017-05-10 16:16:44
Documents
43
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q 03/31/2017 reta-10q_20170331.htm 10-Q 1032181
2 EX-31.1 reta-ex311_9.htm EX-31.1 18954
3 EX-31.2 reta-ex312_6.htm EX-31.2 18877
4 EX-32.1 reta-ex321_7.htm EX-32.1 10176
5 EX-32.2 reta-ex322_10.htm EX-32.2 10168
6 GRAPHIC g20170510200334990640.jpg GRAPHIC 39655
  Complete submission text file 0001564590-17-010251.txt   2897338

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT reta-20170331.xml EX-101.INS 348242
8 XBRL TAXONOMY EXTENSION SCHEMA reta-20170331.xsd EX-101.SCH 23607
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20170331_cal.xml EX-101.CAL 29900
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20170331_def.xml EX-101.DEF 80831
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20170331_lab.xml EX-101.LAB 204117
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20170331_pre.xml EX-101.PRE 155803
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 17830470
SIC: 2834 Pharmaceutical Preparations